Israel stocks lower at close of trade; TA 35 down 0.23%
October 6, 2024
Invizyne Technologies Opens At $11.10, IPO Priced At $8
November 13, 2024
Ethereum fails to hold on to the bullish trend on Tuesday The price of Ethereum rose above the $2500 level...
Read moreBitcoin loses bullish momentum on Monday and drops again The price of Bitcoin rose yesterday to $64444 to a new...
Read moreLibya’s Resumed Oil Production: Brent at $77.54, WTI at $73.65 Following a political standoff that had interrupted Libya’s oil production,...
Read moreTech Regulation Showdown: EU Tightens Grip While US Slows the Pace According to The Pew Research Center survey in February...
Read moreMicrosoft’s $10B AI Bet: Stock Up 10% At the beginning of the year 2024, there was a rapid rise in...
Read moreTesla’s Pivotal October: Robotaxi Event and Q3 Earnings Looming Tesla stock (NASDAQ: TSLA) faces one of its most decisive moments...
Read moreAUDUSD and AUDNZD: New Targets and Prices for Monday Last Friday, AUDUSD retreated to the 0.67856 level, forming a new...
Read moreUSDCHF and USDJPY: New Weekly Targets and Prices During this morning’s Asian trading session, USDCHF is finding support at the...
Read moreEURUSD and GBPUSD: New week, new targets and prices Last week, we saw a drop in EURUSD to 1.09514 levels...
Read moreThe dollar index rose above 102.50 after Friday’s top news On Friday, the dollar index rose to 102.68, forming a...
Read moreDisclaimer: WallStreetJedi.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.